BACKGROUND: Alzheimer's disease is the most common cause of dementia occurring in the elderly. The identification of the genetic factors in the familial forms of the disease enabled the generation of transgenic animals which reproduce an essential part of its pathology. Various lines of transgenic mice expressing human wild-type or mutated APP have been reported. The phenotype expressed in these mice varies according to the transgene itself, the promoter used for its expression, and the level of expression achieved in the brain, but is also determined by the genetic background of the mice. METHODS: We analyzed the variability in the amyloid load by ELISA and the levels of huAPP transcripts by quantitative PCR in our PS2APP double-transgenic mice when expressed in a mixed C57Bl/6, DBA/2 background. RESULTS: In 12-month-old PS2APP double-transgenic mice, the amount of cerebral amyloid deposits is directly correlated with the levels of the huAPP transgenic transcript. Furthermore, a reduction in human APP transcripts by 50% leads to a complete absence of cerebral deposits at the age of 12 months. CONCLUSION: Our results demonstrate that a 2-fold reduction in APP expression can result in a profound decrease in brain pathology. Copyright 2008 S. Karger AG, Basel.
BACKGROUND:Alzheimer's disease is the most common cause of dementia occurring in the elderly. The identification of the genetic factors in the familial forms of the disease enabled the generation of transgenic animals which reproduce an essential part of its pathology. Various lines of transgenic mice expressing human wild-type or mutated APP have been reported. The phenotype expressed in these mice varies according to the transgene itself, the promoter used for its expression, and the level of expression achieved in the brain, but is also determined by the genetic background of the mice. METHODS: We analyzed the variability in the amyloid load by ELISA and the levels of huAPP transcripts by quantitative PCR in our PS2APP double-transgenic mice when expressed in a mixed C57Bl/6, DBA/2 background. RESULTS: In 12-month-old PS2APP double-transgenic mice, the amount of cerebral amyloid deposits is directly correlated with the levels of the huAPP transgenic transcript. Furthermore, a reduction in human APP transcripts by 50% leads to a complete absence of cerebral deposits at the age of 12 months. CONCLUSION: Our results demonstrate that a 2-fold reduction in APP expression can result in a profound decrease in brain pathology. Copyright 2008 S. Karger AG, Basel.
Authors: Brian A Couch; Meghan E Kerrisk; Adam C Kaufman; Haakon B Nygaard; Stephen M Strittmatter; Anthony J Koleske Journal: J Comp Neurol Date: 2013-04-15 Impact factor: 3.215
Authors: Matthias Brendel; Anna Jaworska; Eric Grießinger; Christina Rötzer; Steffen Burgold; Franz-Josef Gildehaus; Janette Carlsen; Paul Cumming; Karlheinz Baumann; Christian Haass; Harald Steiner; Peter Bartenstein; Jochen Herms; Axel Rominger Journal: PLoS One Date: 2015-02-23 Impact factor: 3.240
Authors: Antje Willuweit; Joachim Velden; Robert Godemann; Andre Manook; Fritz Jetzek; Hartmut Tintrup; Gunther Kauselmann; Branko Zevnik; Gjermund Henriksen; Alexander Drzezga; Johannes Pohlner; Michael Schoor; John A Kemp; Heinz von der Kammer Journal: PLoS One Date: 2009-11-20 Impact factor: 3.240
Authors: Vanessa Aires; Claire Coulon-Bainier; Anto Pavlovic; Martin Ebeling; Roland Schmucki; Christophe Schweitzer; Erich Kueng; Simon Gutbier; Eva Harde Journal: Front Immunol Date: 2021-06-01 Impact factor: 7.561
Authors: Matthias Brendel; Gernot Kleinberger; Federico Probst; Anna Jaworska; Felix Overhoff; Tanja Blume; Nathalie L Albert; Janette Carlsen; Simon Lindner; Franz Josef Gildehaus; Laurence Ozmen; Marc Suárez-Calvet; Peter Bartenstein; Karlheinz Baumann; Michael Ewers; Jochen Herms; Christian Haass; Axel Rominger Journal: Front Aging Neurosci Date: 2017-01-31 Impact factor: 5.750